1. Home
  2. CDIO vs VSTD Comparison

CDIO vs VSTD Comparison

Compare CDIO & VSTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

HOLD

Current Price

$1.97

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

VSTD

Vestand Inc.

HOLD

Current Price

$0.21

Market Cap

5.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDIO
VSTD
Founded
2017
2016
Country
United States
United States
Employees
17
259
Industry
Biotechnology: Commercial Physical & Biological Resarch
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
5.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDIO
VSTD
Price
$1.97
$0.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
57.1K
74.6K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$171,906.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.97
$0.20
52 Week High
$7.91
$2.20

Technical Indicators

Market Signals
Indicator
CDIO
VSTD
Relative Strength Index (RSI) 51.87 33.71
Support Level $1.72 $0.22
Resistance Level $2.13 $0.37
Average True Range (ATR) 0.19 0.04
MACD 0.00 -0.01
Stochastic Oscillator 13.57 11.72

Price Performance

Historical Comparison
CDIO
VSTD

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

About VSTD Vestand Inc.

Vestand Inc is a California-based fast-growing restaurant operator expanding into the real estate investment and development sector. It is a PropTech company engaged in AI-driven real estate investment and security token offerings (STOs). It provides services such as Property Acquisition, Property Development, Financial Management, and Property Management.

Share on Social Networks: